Immunogenicity of two oat varieties, in relation to their safety for celiac patients

References

• Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731–43.
   PubMed Web of Science ®Google Scholar
• Buchanan R, Dennis S, Gendel S, Acheson D, Assimon SA, Beru N, Approaches to establish thresholds for major food allergens and for gluten in food. J Food Prot 2008;71:1043–88.
   PubMedGoogle Scholar
• Ciclitira PJ, Ellis HJ, Lundin KE. Gluten-free diet-what is toxic? Best Pract Res Clin Gastroenterol 2005;19:359–71.
   PubMed Web of Science ®Google Scholar
• Tollefsen S, Arentz-Hansen H, Fleckenstein B, Molberg O, Ráki M, Kwok WW, HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin. Invest 2006;116:2226–36.
   Google Scholar
• Camarca A, Anderson RP, Mamone G, Fierro O, Facchiano A, Costantini S, Intestinal T-cell responses to gluten peptides are largely heterogeneous: implication for a peptide-based therapy in celiac disease. J Immunol 2009;182:4158–66.
   PubMed Web of Science ®Google Scholar
• Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003;362:30–7.
   PubMed Web of Science ®Google Scholar
• Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004;21:367–77.
   PubMed Web of Science ®Google Scholar
• Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000;119:996–1006.
   PubMed Web of Science ®Google Scholar
• Mention JJ, Ben Ahmed M, Begue B, Barbe U, Verkarre V, Asnafi V, Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003;125:730–45.
   PubMed Web of Science ®Google Scholar
• Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 1996;111:1706–13.
   PubMedGoogle Scholar
• Barone MV, Gimigliano A, Castoria G, Paolella G, Maurano F, Paparo F, Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut 2007;56:480–8.
   PubMed Web of Science ®Google Scholar
• Barone MV, Nanayakkara M, Paolella G, Maglio M, Vitale V, Troiano R, Gliadin peptide P31–43 localises to endocytic vesicles and interferes with their maturation. PLoS One 2010;5:1–12.
   Google Scholar
• Barone MV, Zanzi D, Maglio M, Nanayakkara M, Santagata S, Lania G, Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. PloS One 2011;6:e17039.
   PubMed Web of Science ®Google Scholar
• Kilmartin C, Wieser H, Abuzakouk M, Kelly J, Jackson J, Feighery C. Intestinal T cell responses to cereal proteins in celiac disease. Dig Dis Sci 2006;51:202–9.
   PubMed Web of Science ®Google Scholar
• Stenman SM, Lindfors K, Venäläinen JI, Hautala A, Männistö PT, Garcia-Horsman JA, Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells. Clin Exp Immunol 2010;161:242–9.
   PubMed Web of Science ®Google Scholar
• Pulido OM, Gillespie Z, Zarkadas M, Dubois S, Vavasour E, Rashid M, Introduction of oats in the diet of individuals with celiac disease: a systematic review. Adv Food Nutr Res 2009;57:235–85.
   PubMedGoogle Scholar
• Lundin KEA, Nilsen EM, Scott HG, Løberg EM, Gjøen A, Bratlie J, Oats induced villous atrophy in coeliac disease. Gut 2003;52:1649–52.
   PubMed Web of Science ®Google Scholar
• Comino I, Real A, De Lorenzo L, Cornell H, López-Casado MA, Barro F, Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease. Gut 2011; Epub ahead of print.
   Google Scholar
• Schulzke JD, Schulzke I, Fromm M, Riecken EO. Epithelial barrier and ion transport in coeliac sprue: electrical measurements on intestinal aspiration biopsy specimens. Gut 1995;37:777–82.
   PubMed Web of Science ®Google Scholar
• Maiuri L, Picarelli A, Boirivant M, Coletta S, Mazzilli MC, De Vincenzi M, Definition of initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996;110:1368–78.
   PubMed Web of Science ®Google Scholar
• Mazzarella G, Maglio M, Paparo F, Nardone G, Stefanile R, Greco L, An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 2003;52:57–62.
   PubMed Web of Science ®Google Scholar
• Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 1995;37:766–76.
   PubMed Web of Science ®Google Scholar
• Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185–94.
   PubMed Web of Science ®Google Scholar
• De Ritis G, Occorsio P, Auricchio S, Gramenzi F, Morisi G, Silano V. Toxicity of wheat flour and protein-derived peptides for in vitro developing intestine from rat fetus. Pediatr Res 1979;13:1255–61.
   PubMed Web of Science ®Google Scholar
• Gianfrani C, Siciliano R, Facchiano A, Camarca A, Mazzeo MF, Costantini S, Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 2007;133:780–9.
   PubMed Web of Science ®Google Scholar
• Gianfrani C, Levings M, Sartirana C, Mazzarella G, Barba G, Zanzi D, Gliadin-specific type-1 regulatory T cells from intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J Immunology 2006;177:4178–86.
   PubMed Web of Science ®Google Scholar
• Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 2008;40:2707–19.
   PubMed Web of Science ®Google Scholar
• Vincentini O, Maialetti F, Gazza L, Silano M, Dessi M, De Vincenzi M, Environmental factors of celiac disease: cytotoxicity of hulled wheat species Triticum monococcum, T. turgidum ssp. dicoccum and T. aestivum ssp. spelta. J Gastroenterol Hepatol 2007;22:1816–22.
   PubMedGoogle Scholar
• Juuti-Uusitalo K, Lindfors K, Mäki M, Patrikainen M, Isola J, Kaukinen K. Inhibition of epithelial growth factor receptor signalling does not preserve epithelial barrier function after in vitro gliadin insult. Scand J Gastroenterol 2009;44:820–5.
   PubMed Web of Science ®Google Scholar
• Jabri B, Ludvig Sollid. Tissue-mediated control of immunopathology in celiac disease. Nature 2009;9:858–70.
   Google Scholar
• Marshall MS. Ras target proteins in eukaryotic cells. FASEB J 1995;9:1311–8.
   PubMed Web of Science ®Google Scholar
• Marsh MN. Studies of intestinal lymphoid tissue. XI–The immunopathology of cell-mediated reactions in gluten sensitivity and other enteropathies. Scanning Microsc 1988;2:1663–84.
   PubMedGoogle Scholar
• Srinivasan U, Jones E, Carolan J, Feighery C. Immunohistochemical analysis of coeliac mucosa following ingestion of oats. Clin Exp Immunol. 2006;144:197–203.
   PubMed Web of Science ®Google Scholar
• Kilmartin C, Lynch S, Abuzakouk M, Wieser H, Feighery C. Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. Gut 2003;52:47–52.
   PubMed Web of Science ®Google Scholar
• Gianfrani C, Auricchio S, Troncone R. Adaptive and innate immune responses in celiac disease. Immunol Lett 2005;99:141–5.
   PubMed Web of Science ®Google Scholar
• Van De Wal Y, Kooy Y, Van Veelen P, Peña S, Mearin L, Papadopoulos G, Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998;161:1585–8.
   PubMed Web of Science ®Google Scholar
• Arentz-Hansen H, Körner R, Molberg O, Quarsten H, Vader W, Kooy YM, The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191:603–12.
   PubMed Web of Science ®Google Scholar
• Arentz-Hansen H, Fleckenstein B, Molberg ø, Scott H, Koning F, Jung G, The molecular basis for oat intolerance in patients with celiac disease. PLoS Med 2004;1:84–92.
   Web of Science ®Google Scholar
• Holm K, Mäki M, Vuolteenaho N, Mustalahti K, Ashorn M, Ruuska T, Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment Pharmacol Ther 2006;23:146372.
   Google Scholar